US EditionHiMedia Laboratories receives CDSCO approval for Hepatitis B and C Molecular Diagnostic Kits - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
HiMedia Laboratories receives CDSCO approval for Hepatitis B and C Molecular Diagnostic Kits - Express Pharma
HiMedia Laboratories Pvt. Ltd. has received manufacturing licences from the Central Drugs Standard Control Organisation (CDSCO) for two molecular diagnostic kits – the Hi-PCR® Hepatitis B Virus (HBV) Detection and Quantitation Probe PCR Kit and the Hi-PCR® Hepatitis C Virus (HCV) Detection and Quantitation Probe PCR Kit. The company stated that the approvals enable HiGenoMB – HiMedia to manufacture the kits on a large scale as part of the Make i…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
